Curt Medeiros on Revolutionizing Precision Medicine and Scaling Ovation

Imagine a future where healthcare isn’t just reactive but deeply personalized — where every patient gets the right treatment at the right time based on a precise understanding of their biology. This is the future Ovation is building, and on this week’s Founded & Funded, Madrona Partner Chris Picardo dives into it all with Ovation CEO Curt Medeiros.

From transforming underutilized clinical data into rich multiomics datasets to forging industry-leading partnerships with companies like Illumina, Curt shares how Ovation is shaping the future of precision medicine. He also opens up about the challenges of building a scalable, privacy-first platform, the lessons he’s brought from leading large healthcare businesses, and why collaboration and diversity are key to solving complex problems in healthcare.

Transcript: https://www.madrona.com/curt-medeiros-on-revolutionizing-precision-medicine-and-scaling-ovation

Chapters:

(00:00) Introduction
(01:32) Ovation's Role in Precision Medicine
(03:17) The Importance of Data in Precision Medicine
(06:12) Challenges and Opportunities of Genomic Data
(11:17) Privacy and Pharmaceutical Applications
(16:42) Ovation's Unique Approach and Partnerships
(17:00) Expanding Research Beyond Pharma
(18:28) Recent Successes and Future Plans
(26:36) Curt Medeiros' Journey to Ovation
(29:56) Leadership Philosophy and Company Culture
(33:21) Future of Precision Medicine